옵션 체인은 다양한 행사가격과 만기일에 대한 Azenta의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Azenta에 대한 시장 심리를 평가합니다..

Azenta (NASDAQ:AZTA) 주식, 옵션 체인

Azenta

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Mid Cap

News

Movers

Trading Ideas

AZTA

IONQ

LCID

OKLO

QBTS

QUBT

RGTI

SOUN

TSLA

XMTR

퀀텀 컴퓨팅, 블랙베리, 루시드 등퀀텀 컴퓨팅, 블랙베리, 루시드 지난주 가장 높은 성과를 올린 중형주 9개 종목은 다음과 같다. 포트폴리오에 포함되어 있는지 확인해 보자.

퀀텀 컴퓨팅, 블랙베리, 루시드 등 지난주 최대 상승한 중형주 (12월 16일~20일)

Azenta Inc

Flex set to join S&P midcap 400; Azenta and Concentra Group to join S&P smallcap 600

Azenta, Inc. (AZTA) has disclosed a new risk, in the Environmental / Social category. Azenta, Inc. faces significant business risks due to its need...

Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks

CDT Insider Sentiment November 2024: Free To Move About The Cabin

Stephens upgraded Azenta (AZTA) to Overweight from Equal Weight with a price target of $60, up from $50. The firm, which says it has been "encourag...

Azenta upgraded to Overweight, named new 'Best Idea' at Stephens

2024's 'Biggest loses' that could see reversal in 2025

2024's 'Biggest losers' that could see reversal in 2025

Evercore ISI raised the firm's price target on Azenta (AZTA) to $50 from $48 and keeps an In Line rating on the shares. In the firm's 2025 outlook ...

Azenta price target raised to $50 from $48 at Evercore ISI

Stephens analysts presented the firm's 2025 Best Ideas list, which includes Valley National (VLY), CoStar Group (CSGP), Castle Biosciences (CSTL), ...

Stephens lays out 21 Best Ideas for 2025

ClearBridge Small Cap Growth Strategy Q4 2024 Commentary

Corporate candidates to announce accelerate share buybacks: Trivariate

AFMC

ALGM

ALHC

AMRK

ANDE

ANSS

ARKK

ARWR

ATGE

AZEK

AZPN

BBMC

BFOR

BKMC

BLFS

BLKB

BMRC

BMVP

BOUT

BPMC

CACI

CBRL

CDNS

CERT

CGNX

COHU

CSGP

CSTL

CTKB

CVNA

CWAN

DDIV

DEUS

DIOD

DVLU

EQAL

ETHO

FFSM

FFTY

FIVE

FLEX

FLQM

FOUR

FOVL

FRTY

FSCS

FSMD

FTDS

GNTX

GRPM

GWRE

HAIL

HALO

HAYW

HLGE

HOMZ

HTLD

ICLN

IMCB

IMCG

IMCV

INFR

IVOG

IVOO

IVOV

JHMM

JPME

JSMD

KLAC

KOMP

LRGE

LSAT

LSCC

MATX

MDYG

MDYV

MIDE

NUMG

NUMV

ONEO

ONEV

ONEY

OSCR

PAMC

PCVX

PEXL

PGNY

POWI

PRVA

PTMC

QDEL

QMOM

QQQJ

QVAL

QVMM

REGL

RSPT

SCHM

SDGR

SDVY

SFYX

SGRY

SHLS

SIXL

SNPS

SPGI

SPMD

SQEW

STKL

SWKS

SYLD

SYNA

TGTX

TMDV

TPHD

TPLC

ULTA

UPGD

USMF

VFMF

VFMO

VFMV

VFQY

VFVA

VIAV

VRAI

VRNS

VRSN

VUSE

WBIY

WING

XMHQ

XMLV

XMMO

XMVM

YLDE

ZETA

Press Releases

Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Earnings

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta to Participate in Stephens Annual Investment Conference

Mutual Funds

Markets

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

LVWR

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Comments

Azenta

Azenta (AZTA) 옵션

Azenta (NASDAQ:AZTA) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌